SoylentNews is people
SoylentNews
The FDA has approved a new drug for Alzheimer's disease, while not a cure it is supposed to slow the decline. Even though data is not entirely positive or straight forward in its interpretation or that it will actually even work as thought.
But if you have it then you are probably desperate enough to try almost anything that claims to work, until you get to the price tag of $56,000 per year. That will probably make it out of reach for most people, it's doubtful if any insurance will cover something like this. Perhaps you can just forget to pay the bill, they might understand due to your condition.
Biogen CEO Michel Vounatsos [...][said] he thought the drug's price was "fair" but also vowed that the company would not hike its price for four years.
Previously:
In Surprise Turnaround, Biogen to Submit Previously Failed Alzheimer Drug for Approval
Disputed Alzheimer's Study Links Decrease in Amyloid Levels to Reduction in Cognitive Decline
Positive Result in Mice as Alzheimer's Drug Trials Fail and Regulatory Barriers Are Rolled Back
(Score: 2) by DannyB on Wednesday June 09 2021, @08:23PM (1 child)
Would someone suffering from Alzheimer's remember that the data is very sketchy?
Or remember the promise not to hike the price for years?
To transfer files: right-click on file, pick Copy. Unplug mouse, plug mouse into other computer. Right-click, paste.
(Score: 2) by stretch611 on Thursday June 10 2021, @04:05AM
Well, if the drug fails to work, the people taking it will forget to pay for it (or forget to refill it.)
Now with 5 covid vaccine shots/boosters altering my DNA :P